LU Zhenhui,QIU Lei,ZHANG Shaoyan,et al.Discussion on the Change of Cold-dampness and Retained Fluid Blocking Lung with Fire Deficiency of Mingmen (the gate of life) in Severe Patients with Coronavirus Disease 2019[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):15-17.[doi:10.3969/j.issn.1005-5304.202002161]
试论新型冠状病毒肺炎重症“寒湿水饮闭肺，命门之火不振”之变
- Title:
- Discussion on the Change of Cold-dampness and Retained Fluid Blocking Lung with Fire Deficiency of Mingmen (the gate of life) in Severe Patients with Coronavirus Disease 2019
- 文章编号:
- 1005-5304(2020)08-0015-03
- Keywords:
- COVID-19; severe patient; cold-dampness and retained fluid; fire of Mingmen; ruling water with fire; treating tri-jiao simultaneously
- 分类号:
- R259.631
- 文献标志码:
- A
- 摘要:
- 随着临床介入程度的逐渐加强，中医对新型冠状病毒肺炎的认识不断深入，尤其“湿毒”作为重要病理因素已基本达成共识，然其病机及传变规律仍需尽快完善，以推动优化形成更加有效的中医药诊疗共性方案。本文基于一线临床和相关文献，审证求因，提出“寒湿水饮闭肺，命门之火不振”为新型冠状病毒肺炎重症患者的重要病机，治当“以火治水，三焦同治”，拟方可参照射干麻黄汤、真武汤、附子理中汤等温煦三焦以固其本，兼以解毒通腑利水之法而治其标。该方案体现标本兼治、寒温并用、攻补兼施，灵活辨证组方，谨守药性之平衡，可为临床辨治新型冠状病毒肺炎提供参考。
- Abstract:
- Traditional Chinese Medicine (TCM) practitioners have deepened their understanding of the disease theory with the gradually increasing degree of clinical intervention of coronavirus disease 2019 ( COVID-19). Especially, “Dampness Toxin” as the core of TCM pathogenesis has reached consensus. However, the comprehension on the pathogenesis and transmission laws of COVID-19 still need to be quickly improved in order to promote optimization to form a more effective common regimen for diagnosis and treatment of TCM on COVID-19. The author’s team based on first-line clinical and academic data verified the cause and proposed that “cold-dampness and retained fluid blocking lung with fire deficiency of Mingmen” be important pathogenesis of severe patients with COVID-19. And the treatment principle should follow “ruling water with fire, and treating tri-jiao simultaneously”. The prescription should refer to Shegan Mahuang Decoction, Zhenwu Decoction, Fuzi Lizhong Decoction and other formulas to warm tri- jiao, which aims to consolidate the essence of human body. “Detoxification, dredging six-Fu organs and diuresis” also need to be considered to alleviate the symptoms at the same time. This regimen reflects the consideration of both the symptoms and causes, the combination of cold and warm medicinal herbs, tonification and purgation in combination, flexibility in syndrome differentiation and prescription and careful grasp of the balance of the property of herbs, which can provide a reference for clinical diagnosis and treatment on COVID-19.
参考文献/References:
[1] 中华人民共和国卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第五版修正版)的通知[EB/OL].(2020-02-08)[2020-02-08]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml. [2] 苑鑫,牟劲松,磨国鑫,等.新型冠状病毒肺炎呼吸支持手段介入的时机与策略[J].中华结核和呼吸杂志,2020,43(3)：E010-E010.DOI： 10.3760/cma.j.issn.1001-0939.2020.0010. [3] 湖北省卫生健康委员会.“新型冠状病毒感染的肺炎疫情防控工作”新闻发布会信息发布[EB/OL].(2020-02-14)[2020-02-15].http:// wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/xxfb/202002/t20200214_2027715.shtml. [4] 中华人民共和国中央人民政府.仝小林院士“解读”《新型冠状病毒感染的肺炎诊疗方案(试行第四版)》中的中医治疗方案[EB/OL]. (2020-01-28)[2020-02-12].http://www.gov.cn/zhengce/2020-01/28/ content_5472789.htm. [5] 王宁.北京中医医院院长刘清泉武汉归来,谈新型冠状病毒肺炎[N/OL].健康报.(2020-01-27)[2020-02-12].http://www.jkb.com. cn/hotTopics/zjlx/2020/0127/469111.html. [6] 王玉光,齐文升,马家驹,等.新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探[J/OL].中医杂志[2020-02-11].http://kns. cnki.net/kcms/detail/11.2166.R.20200129.1258.002.html. [7] 李光熙.半副人参败毒散退“冠状病毒”之热[Z/OL]. (2020-02-04)[2020-02-12].https://www.jingfangpai.cn. [8] 苗青,丛晓东,王冰,等.新型冠状病毒感染的肺炎的中医认识与思考[J/OL].中医杂志[2020-02-15].http://kns.cnki.net/kcms/ detail/11.2166.R.20200205.1606.002.html. [9] 史河水,韩小雨,樊艳青,等.新型冠状病毒(2019-nCoV)感染的肺炎临床特征及影像学表现[J/OL].临床放射学杂志[2020-02-15]. https://doi.org/10.13437/j.cnki.jcr.20200206.002. [10] 管汉雄,熊颖,申楠茜,等.2019新型冠状病毒(2019-nCoV)肺炎的临床影像学特征初探[J/OL].放射学实践[2020-02-15]. https://doi.org/10.13609/j.cnki.1000-0313.2020.02.001. [11] 倪伟,吴银根,张惠勇.温阳抗寒合剂对哮喘模型大鼠sVCAM-1及IL-4与IL-5的影响[J].上海中医药大学学报,2008,22(3)：61-63. [12] 喻晓,方泓,吴银根,等.咳喘六味合剂对RSV感染哮喘小鼠气道炎症的影响[J].辽宁中医杂志,2013,40(5)：1020-1023.
相似文献/References:
[1]龚新月,魏大荣,龚雪,等.重庆市万州区80例新型冠状病毒肺炎患者临床特征及证治分析[J].中国中医药信息杂志,2020,27(7):24.[doi:10.3969/j.issn.1005-5304.202002560]
GONG Xinyue,WEI Darong,GONG Xue,et al.Analysis on Clinical Characteristics and TCM Syndromes of 80 Patients with Novel Coronavirus Pneumonia in Wanzhou District of Chongqing[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):24.[doi:10.3969/j.issn.1005-5304.202002560]
[2]宋忠阳,雍文兴,李娟,等.甘肃地区60例普通型新型冠状病毒肺炎患者中医证候规律分析[J].中国中医药信息杂志,2020,27(7):29.[doi:10.3969/j.issn.1005-5304.202002569]
SONG Zhongyang,YONG Wenxing,LI Juan,et al.Analysis on TCM Syndrome Rules of 60 Cases of Novel Coronavirus Pneumonia in Gansu Area[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):29.[doi:10.3969/j.issn.1005-5304.202002569]
[3]田伟,刘赓,张晓颖,等.新型冠状病毒肺炎中西医结合呼吸康复方案（草案）[J].中国中医药信息杂志,2020,27(8):1.[doi:10.3969/j.issn.1005-5304.202002433]
TIAN Wei,LIU Geng,ZHANG Xiaoying,et al.Respiratory Rehabilitation Program (Draft) of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19)[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):1.[doi:10.3969/j.issn.1005-5304.202002433]
[4]王进忠,谢文源,覃小兰,等.基于文献探讨膜原学说在新型冠状病毒肺炎中的临床应用[J].中国中医药信息杂志,2020,27(9):21.[doi:10.3969/j.issn.1005-5304.202002354]
WANG Jinzhong,XIE Wenyuan,QIN Xiaolan,et al.Clinical Application of Moyuan Theory in Coronavirus Disease 2019 Based on Literature Reports[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):21.[doi:10.3969/j.issn.1005-5304.202002354]
[5]周红光.试论新型冠状病毒肺炎中医药防治[J].中国中医药信息杂志,2020,27(9):25.[doi:10.3969/j.issn.1005-5304.202002171]
ZHOU Hongguang.Discussion on Prevention and Treatment of Coronavirus Disease 2019 with TCM[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):25.[doi:10.3969/j.issn.1005-5304.202002171]
[6]魏本君,王庆胜,雍文兴,等.甘肃新型冠状病毒肺炎特征及中医治疗[J].中国中医药信息杂志,2020,27(10):13.[doi:10.19879/j.cnki.1005-5304.202002233]
WEI Benjun,WANG Qingsheng,YONG Wenxing,et al.Characteristics of Novel Coronavirus Pneumonia and TCM Treatment in Gansu[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):13.[doi:10.19879/j.cnki.1005-5304.202002233]
[7]刘铁钢,白辰,刘邵阳,等.基于系统药理学探究新型冠状病毒肺炎中医病机[J].中国中医药信息杂志,2020,27(11):99.[doi:10.19879/j.cnki.1005-5304.202003215]
LIU Tiegang,BAI Chen,LIU Shaoyang,et al.Exploration on TCM Pathogenesis of COVID-19 Based on Systematic Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):99.[doi:10.19879/j.cnki.1005-5304.202003215]
备注/Memo
基金项目：国家“十三五”传染病重大专项课题（2017ZX10305501-002）；上海市中医药防治新型冠状病毒肺炎应急专项（2020COVID-19001）；上海市科委“国内科技合作领域和长三角科技联合攻关领域”项目（18495810600）
更新日期/Last Update:
2020-07-20